Progyny, Inc. Financing Cash Flow
Progyny, Inc. (PGNY) reported Financing Cash Flow of -$156.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-07
- Progyny, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$32.89M.
- Progyny, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$123.11M.
- Progyny, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$88.26M.
- Progyny, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$5.49M.
- Progyny, Inc. net cash provided by (used in) financing activities for fiscal 2025 was -$99.36M.
- Progyny, Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$309.88M.
- Progyny, Inc. net cash provided by (used in) financing activities for fiscal 2023 was -$11.07M.
- Progyny, Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$7.86M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$32.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$156.01M 10-Q · filed 2026-08-07 | -$244.27M derived: sum of 3 quarters · filed 2026-08-07 | -$249.75M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$123.11M 10-Q · filed 2026-05-08 | -$211.37M derived: sum of 2 quarters · filed 2026-05-08 | -$216.86M derived: sum of 3 quarters · filed 2026-05-08 | -$219.19M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$88.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$93.75M derived: sum of 2 quarters · filed 2026-02-27 | -$96.07M derived: sum of 3 quarters · filed 2026-08-07 | -$99.36M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$5.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$7.82M derived: sum of 2 quarters · filed 2026-08-07 | -$11.10M 10-Q · filed 2025-11-07 | -$67.43M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$5.62M 10-Q · filed 2026-08-07 | -$61.94M derived: sum of 3 quarters · filed 2026-08-07 | -$125.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$3.29M 10-Q · filed 2026-05-08 | -$59.62M derived: sum of 2 quarters · filed 2026-05-08 | -$122.97M derived: sum of 3 quarters · filed 2026-05-08 | -$285.76M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$56.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$119.68M derived: sum of 2 quarters · filed 2026-02-27 | -$282.47M derived: sum of 3 quarters · filed 2026-02-27 | -$309.88M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$63.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$226.14M derived: sum of 2 quarters · filed 2025-11-07 | -$253.55M 10-Q · filed 2025-11-07 | -$258.58M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$162.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$190.20M 10-Q · filed 2025-08-08 | -$195.22M derived: sum of 3 quarters · filed 2026-02-27 | -$197.59M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$27.41M 10-Q · filed 2025-05-09 | -$32.44M derived: sum of 2 quarters · filed 2026-02-27 | -$34.80M derived: sum of 3 quarters · filed 2026-02-27 | -$36.64M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$5.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$7.39M derived: sum of 2 quarters · filed 2026-02-27 | -$9.23M derived: sum of 3 quarters · filed 2026-02-27 | -$11.07M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$4.20M derived: sum of 2 quarters · filed 2024-11-12 | -$6.05M 10-Q · filed 2024-11-12 | -$8.83M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$3.69M 10-Q · filed 2024-08-07 | -$6.47M derived: sum of 3 quarters · filed 2025-03-03 | -$7.70M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$1.85M 10-Q · filed 2024-05-10 | -$4.63M derived: sum of 2 quarters · filed 2025-03-03 | -$5.86M derived: sum of 3 quarters · filed 2025-03-03 | -$7.94M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$4.01M derived: sum of 2 quarters · filed 2025-03-03 | -$6.09M derived: sum of 3 quarters · filed 2025-03-03 | -$7.86M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$3.31M derived: sum of 2 quarters · filed 2023-11-08 | -$5.08M 10-Q · filed 2023-11-08 | -$8.39M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$3.85M 10-Q · filed 2023-08-04 | -$7.16M derived: sum of 3 quarters · filed 2024-02-29 | -$10.22M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$1.77M 10-Q · filed 2023-05-09 | -$5.09M derived: sum of 2 quarters · filed 2024-02-29 | -$8.15M derived: sum of 3 quarters · filed 2024-02-29 | -$12.97M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$6.37M derived: sum of 2 quarters · filed 2024-02-29 | -$11.20M derived: sum of 3 quarters · filed 2024-02-29 | -$13.70M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$7.88M derived: sum of 2 quarters · filed 2022-11-04 | -$10.38M 10-Q · filed 2022-11-04 | -$12.46M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$4.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$7.32M 10-Q · filed 2022-08-05 | -$9.40M derived: sum of 3 quarters · filed 2023-03-01 | -$11.01M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$2.50M 10-Q · filed 2022-05-06 | -$4.58M derived: sum of 2 quarters · filed 2023-03-01 | -$6.19M derived: sum of 3 quarters · filed 2023-03-01 | -$8.55M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$3.69M derived: sum of 2 quarters · filed 2023-03-01 | -$6.05M derived: sum of 3 quarters · filed 2023-03-01 | -$6.25M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$3.97M derived: sum of 2 quarters · filed 2021-11-08 | -$4.17M 10-Q · filed 2021-11-08 | $76.32M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$2.56M 10-Q · filed 2021-08-06 | $77.93M derived: sum of 3 quarters · filed 2022-03-01 | $79.83M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$194.00K 10-Q · filed 2021-05-07 | $80.29M derived: sum of 2 quarters · filed 2022-03-01 | $82.20M derived: sum of 3 quarters · filed 2022-03-01 | $78.02M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $80.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $82.39M derived: sum of 2 quarters · filed 2022-03-01 | $78.21M derived: sum of 3 quarters · filed 2022-03-01 | $84.55M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$2.27M derived: sum of 2 quarters · filed 2020-11-06 | $4.06M 10-Q · filed 2020-11-06 | $44.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$4.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $2.15M 10-Q · filed 2020-08-07 | -$1.86M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $6.33M 10-Q · filed 2020-05-14 | $2.32M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | -$4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$8.74M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$4.72M 10-Q · filed 2019-12-06 | |||
| 2017-12-31 | $11.77M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |